At an individual level Helicobacter pylori was associated with the occurrence of gastric cancer but in some African and Asian countries its prevalence runs with low gastric cancer rates, the so-called African and Asian enigmas. We assessed whether the association between gastric cancer and H. pylori
CagA+ Helicobacter pylori infection and gastric cancer risk in the EPIC-EURGAST study
✍ Scribed by Domenico Palli; Giovanna Masala; Giuseppe Del Giudice; Mario Plebani; Daniela Basso; Duccio Berti; Mattijs E. Numans; Marco Ceroti; Petra H.M. Peeters; H. Bas Bueno de Mesquita; Frederike L. Buchner; Francoise Clavel-Chapelon; Marie-Christine Boutron-Ruault; Vittorio Krogh; Calogero Saieva; Paolo Vineis; Salvatore Panico; Rosario Tumino; Olof Nyrén; Henrik Simán; Goran Berglund; Goran Hallmans; Maria-Jose Sanchez; Nerea Larrãnaga; Aurelio Barricarte; Carmen Navarro; Jose R. Quiros; Tim Key; Naomi Allen; Sheila Bingham; Kay Tee Khaw; Heiner Boeing; Cornelia Weikert; Jakob Linseisen; Gabriele Nagel; Kim Overvad; Reimar W. Thomsen; Anne Tjonneland; Anja Olsen; Antonia Trichoupoulou; Dimitrios Trichopoulos; Athina Arvaniti; Guillem Pera; Rudolf Kaaks; Mazda Jenab; Pietro Ferrari; Gabriella Nesi; Fatima Carneiro; Elio Riboli; Carlos A. Gonzalez
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- French
- Weight
- 246 KB
- Volume
- 120
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Helicobacter pylori (H. pylori), atrophic gastritis, dietary and life‐style factors have been associated with gastric cancer (GC). These factors have been evaluated in a large case–control study nested in the European Prospective Investigation into Cancer and Nutrition carried out in 9 countries, including the Mediterranean area. Participants, enrolled in 1992–1998, provided life‐style and dietary information and a blood sample (360,000; mean follow‐up: 6.1 years). For 233 GC cases diagnosed after enrolment and their 910 controls individually‐matched by center, gender, age and blood donation date H. pylori antibodies (antilysate and antiCagA) and plasma Pepsinogen A (PGA) were measured by ELISA methods. Severe chronic atrophic gastritis (SCAG) was defined as PGA circulating levels <22 μg/l. Overall, in a conditional logistic regression analysis adjusted for education, smoke, weight and consumption of total vegetables, fruit, red and preserved meat, H. pylori seropositivity was associated with GC risk. Subjects showing only antibodies anti‐H. pylori lysate, however, were not at increased risk, while those with antiCagA antibodies had a 3.4‐fold increased risk. Overall, the odds ratio associated with SCAG was 3.3 (95% CI 2.2–5.2). According to site, the risk of noncardia GC associated with CagA seropositivity showed a further increase (OR 6.5; 95% CI 3.3–12.6); on the other hand, a ten‐fold increased risk of cardia GC was associated with SCAG (OR 11.0; 95% CI 3.0–40.9). These results support the causal relationship between H. pylori CagA+ strains infection, and GC in these European populations even after taking into account dietary habits. This association was limited to distal GC, while serologically defined SCAG was strongly associated with cardia GC, thus suggesting a divergent risk pattern for these 2 sites. © 2006 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract Several polymorphisms of the __IL1B__ and __IL10__ gene promoters have been reported to be associated with gastric cancer risk in Caucasians. However, studies in other populations have shown differing results. We aimed to test for associations between polymorphisms in __IL1B__ (__−31__
## Background: P53 mutations are an early event in the multistep progression of gastric carcinoma. these mutations are often present in dysplastic and intestinal metaplastic gastric epithelium. however, the presence of immunohistochemically detectable p53 protein and p53 mutations in nondysplastic/
## Background: Squamous cell carcinoma of the laryngopharynx has been linked to laryngopharyngeal reflux disease. helicobacter pylori corpus gastritis decreases gastric acid secretion and provides some protection against complications of gastroesophageal reflux, including adenocarcinoma of the dist